Product Information
TOPIRAMATE ER 150 MG SPRINK CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $8.8317 per EA under NDC 68462037030. Its NADAC has been published 217 times since Mar 3, 2021.
Strength
150 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462037030
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA210278On Market Since
2/1/2021
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has been published 217 times since Mar 3, 2021, and over the history we have for it it has declined 57.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.8317 per EA |
|---|---|
| All-time high | $20.7995 (May 12, 2021) |
| All-time low | $8.8317 (Jun 17, 2026) |
| 52-week high | $12.4622 |
| 52-week low | $8.8317 |
| Median price | $12.4409 |
| Average price | $14.1099 |
| Largest weekly change | +54.2% (Oct 18, 2023) |
| Weeks tracked | 217 |
| Tracking since | Mar 3, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 150 MG SPRINK CAP?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 150 MG SPRINK CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $8.8317 per EA (NDC 68462037030), effective Jun 24, 2026.
How has the price of TOPIRAMATE ER 150 MG SPRINK CAP changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has declined 57.5%. It has been tracked across 217 weekly CMS publications since Mar 3, 2021.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 150 MG SPRINK CAP?
Since Mar 3, 2021, the NADAC for TOPIRAMATE ER 150 MG SPRINK CAP has ranged from a low of $8.8317 (Jun 17, 2026) to a high of $20.7995 (May 12, 2021), with a median of $12.4409 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 150 MG SPRINK CAP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TOPIRAMATE ER 150 MG SPRINK CAP, but none are currently priced below it.
Who manufactures TOPIRAMATE ER 150 MG SPRINK CAP?
TOPIRAMATE ER 150 MG SPRINK CAP (NDC 68462037030) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification